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Quantitativemeasuresofcartilagemorphology(i.e.,thickness)representpotentiallypowerfulsurrogateendpointsinosteoarthritis
(OA). These can be used to identify risk factors of structural disease progression and can facilitate the clinical eﬃcacy testing
of structure modifying drugs in OA. This paper focuses on quantitative imaging of articular cartilage morphology in the knee,
and will speciﬁcally deal with diﬀerent cartilage morphology outcome variables and regions of interest, the relative performance
and relationship between cartilage morphology measures, reference values for MRI-based knee cartilage morphometry, imaging
protocols for measurement of cartilage morphology (including those used in the Osteoarthritis Initiative), sensitivity to change
observed in knee OA, spatial patterns of cartilage loss as derived by subregional analysis, comparison of MRI changes with
radiographic changes, risk factors of MRI-based cartilage loss in knee OA, the correlation of MRI-based cartilage loss with clinical
outcomes, treatment response in knee OA, and future directions of the ﬁeld.
1.Introduction
Magnetic resonance imaging (MRI) has revolutionized the
ﬁeld of clinical research in osteoarthritis (OA) because
it can directly visualize all diarthrodial tissues, including
cartilage, bone, menisci, ligaments, synovium, and others.
As it has been recognized that OA is a disease of the
entire joint, involving most (if not all) of the above tissues,
MRI has substantial advantages over radiography, which can
only delineate the bone. Owing to its three-dimensional
coverage of anatomical structures [1, 2]( Figure 1), MRI
additionally permits to obtain quantitative measures of
relevant tissue structures (and their changes over time)
in OA. Quantitative measures of cartilage morphology
(i.e., thickness, volume, surface areas) represent potentially
powerful surrogate endpoints in osteoarthritis (OA). These
can be used to identify risk factors of structural disease
progression and can facilitate the clinical eﬃcacy testing of
disease (or structure) modifying drugs in OA (DMOADs),
which are not clinically available to date.
This paper will focus on the knee, as most of the
quantitative cartilage imaging work has been performed in
that joint. It will further focus on the cartilage, as this
the tissue that has generated most interest in context of
quantitative measurement in OA using MRI. Last, we will
focus on quantitative cartilage morphology (i.e., thickness,
surface areas, volume) but will not cover quantitative
MRI techniques measuring cartilage composition, such as
dGEMRIC, T2, T1rho, and others [3].
Quantitative measurements of cartilage morphology
(structure)fullyexploitthe3DnatureofMRIdatasets[1,2];
their strength is that they are less observerdependent and
more objective than scoring methods, and that relatively
small changes in cartilage thickness, which occur relatively
homogeneously over larger areas may be detected over time,
which are not apparent to the naked eye. This is important,
as the progression of structural changes in OA has generally
been shown to be slow, both when being evaluated by
radiography [4–6]a n dM R I[ 6–10]. A recent study found
thatquantitativemeasuresofcartilagemorphology[11]were
more powerful in revealing relationships between local risk
factors (meniscus damage and malalignment) and knee car-
tilage loss than a semi-quantitative approach using ordinal
scales (i.e., whole organ MRI score) [12]. The disadvantage
of quantitative measurement, however, is that it requires
specializedsoftwareandismoretimeintensivebecausetissue2 Arthritis
boundaries need to be tracked (i.e., segmented) throughout
large series of slices using trained technical personnel.
Also, quantitative measurements are less sensitive to the
occurrences of small focal changes within larger structures
(i.e., cartilage lesions), which may be readily picked up
by an expert reader, particularly if the location within the
larger structure is variable from joint to joint. A recent
study showed, for instance, that MRI-based semiquantitative
scoring of cartilage status was able to diﬀerentiate between
knees with and without early (i.e., Kellgren-Lawrence grade
[KLG] 2) radiographic OA, whereas quantitative measures
of cartilage morphology displayed no or little diﬀerence
between healthy and KLG2 knees [13]. It thus depends on
the context and on the speciﬁc research question, whether
or not quantitative cartilage assessment is better suited as
an outcome measures for a particular study than semi-
quantitative measures. Ideally, both approaches should be
used in complimentary rather than competing fashion in
studies assessing either the status or the progression of OA.
Focusing on quantitative imaging of cartilage morphol-
ogy in the knee, this paper will sequentially address
(i) diﬀerent cartilage morphology outcome variables
and regions of interest in the knee,
(ii) the relative performance and relationship between
cartilage morphology measures,
(iii) imaging protocols for measurement of cartilage mor-
phology, including validation,
(iv) rates of change and sensitivity to change observed in
knee OA.
(v) spatial patterns of cartilage loss in knee OA as derived
by subregional analysis,
(vi) comparison of MRI changes with radiographic chan-
ges in knee OA,
(vii) risk factors of cartilage loss in the knee as identiﬁed
by quantitative cartilage MR imaging,
(viii) the correlation of MRI-based cartilage loss with clin-
ical outcomes, and treatment response in knee OA,
(xi) future directions of the ﬁeld.
2. Cartilage Morphology Outcome Variables
andRegions of Interestin the Knee
A consensus-based nomenclature for the above-mentioned
structural (i.e., morphological metric labels) or composi-
tional features as well as deﬁnitions for regions of interest
in the knee (i.e., anatomical labels, see Table 1 and Figure 2)
has been proposed by a group of experts [14]. The
above nomenclature will be used throughout this paper,
and important abbreviations for morphology metrics and
anatomical regions of interests including recent extensions
(i.e., statistical labels and subregional labels, i.e., [15]) are
summarized in Table 1. Cartilage morphology outcomes
(a)
(b)
Figure 1: 3D reconstruction of the knee cartilages after segmen-
tation: (a) View from anteromedial with softtissues in grey (b)
View from anterior-lateral, with the bone segmented and with
the cartilage thickness distribution in the patella displayed in false
colors (red: thick cartilage; blue: thin cartilage). The cartilage of the
medial tibia (MT) is depicted dark blue, that of the lateral tibia (LT)
green), that of the medial weight-bearing femoral condyles (cMF)
yellow, that of the lateral weight-bearing femoral condyles (cLF)
red, that of the patella (P) magenta, and that of the femoral trochlea
(TrF) turquoise. Segmentation was performed based on a 3D-DESS
knee imaging data set from the Osteoarthritis Initiative (OAI),
a public-private partnership funded by the National Institutes
of Health and conducted by the OAI Study Investigators. For
anatomical (region of interest) labels, also see Figure 2 and Table 1.
commonly include the size of the total area of subchondral
bone (tAB), the area of the cartilage surface (AC), the
denuded(dAB)andcartilagecovered(cAB)areaofsubchon-
dral bone, the cartilage thickness over the tAB (ThCtAB)
or over the cAB (ThCcAB), the cartilage volume (VC),
the cartilage volume normalized to the tAB (VCtAB), the
cartilage signal intensity [16–18], and others (Table 1).
To obtain the above quantitative morphological mea-
sures of cartilage, the relevant cartilage plates of a joint need
to be segmented by a trained user with the choice of several
input devices [19], with or without assistance from (semi-
automated) segmentation software [20–28]. Because the
relative performance of diﬀerent segmentation algorithms
has been discussed in previous reviews [9], this point willArthritis 3
Table 1:Morphological(metrics),statistical,andanatomical(regionofinterest)labelscommonlyusedincartilagemorphologypublications
on the knee.
Abbreviation Explanation Unit
Morphological (metrics) label
VC volume of the cartilage (mm3/mL)
tAB total area of subchondral bone (cm2)
AC area of cartilage surface (cm2)
cAB area of tAB covered by AC (cm2)
dAB% percent of tAB denuded (not covered by AC) (%)
VCtAB volume of the cartilage divided by tAB (mm)
ThCtAB thickness of the cartilage over the entire tAB (mm)
ThCcAB thickness of cartilage over cAB (mm)
dAB% percent of tAB denuded (not covered by AC) (%)
VCtAB volume of the cartilage divided by tAB (mm)
ThCtAB thickness of the cartilage over the entire tAB (mm)
ThCcAB thickness of cartilage over cAB (mm)
Statistical labels
Me mean (i.e., thickness)
Max maximum (i.e., thickness)
Mav maximal averaged, for example, mean of the top
1% values
Min minimum (i.e., thickness)
Miv minimum averaged, for example, mean of the
lowest 1% values
SD standard deviation (i.e., thickness)
CV% coeﬃcient of variation (i.e., thickness)
c(Me, Mav) thickness measured from cartilage surface (AC) to
bone interface (tAB)
b(Me, Mav) thickness measured from bone interface (tAB) to
cartilage surface (AC)
a(Me, Mav) average of the two above (b, c)
Anatomical (region of interest) labels
Total cartilage plates
PP a t e l l a
MT Medial tibia
LT Lateral tibia
FF e m u r
TrF Femoral trochlea
MF Medial femoral condyle
cMF weight-bearing portion of MF
pMF posterior portion of MF
LF Lateral femoral condyle
cLF weight-bearing portion of LF
pLF posterior portion of LF
MFTC aggregate values for MT and cMF (MT + cMF)
LFTC aggregate values for LT and cLF (LT + cLF)
Subregions (to be combined with above total plate labels, i.e., cMT or ccMF)
cc e n t r a l
e external
i internal
a anterior
pp o s t e r i o r
For anatomical (region of interest) labels, also see Figures 1 and 2.4 Arthritis
notbecoveredindepthinthischapter.Usingtheabovetools,
an operator needs to accurately trace both the bone-cartilage
interface (i.e., the subchondral bone surface; tAB), and the
surface of the cartilage, respectively (AC). The tracing of the
tAB should include dABs, but not (peripheral) osteophyte
surfaces.AstherearevarioussourcesofartifactsonMRI,and
because signal intensity and contrast may vary substantially
between baseline and followup acquisitions, there exists a
current consensus that expert quality control is important
for accurate analyses; the time required for segmentation of
the cartilages or for the correction of computer-generated
segmentation may take several hours per knee joint. After
all slices of interest have been segmented, image analysis
software can be used to compute the three-dimensional
morphological features listed in Table 1.
Anatomical regions of interest in the knee are listed
and explained in Table 1 and Figure 2. Since the weight-
bearing (cMF, cLF) and posterior aspects (pMF and pLF)
of the femoral condyles are continuous and lack a deﬁnite
anatomical border, diﬀerent deﬁnitions for these ROIs have
been proposed: Glaser et al. [32] used the projection of the
posterior intercondylar bone bridge as a cutoﬀ between the
weight-bearingandposteriorzone,whereaslaterstudies[33]
introduced a 60% distance criterion between the trochlear
notch and the most posterior aspects of both femoral
condyles as a cutoﬀ between both regions (Figure 2). In a
face-to-face comparison, the work in [34] reported the tAB
of the 60% ROI to be approximately 20% greater and less
variable (between subjects) than that based on the bone
bridge, with cartilage morphology metrics being generally
more reproducible in the 60% ROI. However, thickness
measures did not diﬀer signiﬁcantly between both ROIs, and
the longitudinal rate of change and standardized response
mean (SRM = mean change/SD of change, as a measure of
sensitivity to change) over two years were similar for both
ROIs. Using sagittal images, both 60% [33]( Figure 2)a n d
75%[35,36]cutoﬀshavebeenused,the60%cutoﬀassigning
36 (±1.8%) of the tAB of MF to the weight bearing (cMF)
and 64% to the posterior portion (pMF), whereas the 75%
cutoﬀ assigns 47% (±2.0%) of the tAB to cMF and 53% to
pMF, respectively [36]. Again, the mean change and SRM
were similar for both the 60% and the 75% ROI [36]. The
(weight-bearing) medial femorotibial compartment (MT +
cMF) is commonly addressed as MFTC, and the lateral
c o m p a r t m e n t( L T+c L F )a sL F T C( Figure 2).
Quantitative measures of surface curvature and joint
incongruity have also been determined from MR images
[37] and were observed to discriminate between subjects
with various radiographic OA grades cross-sectionally at
0.2T [38, 39]. Curvature estimates at diﬀerent scales (at
0.2T) were reported to be associated with the magnitude of
cartilage loss longitudinally [40] and cartilage homogeneity
(quantiﬁed by measuring entropy from the distribution of
signal intensities in tibial cartilage from 0.2T gradient echo
images) was reported to discriminate between subjects with-
out and with early radiographic OA [18]. This measure was
proposed to be particularly sensitive in peripheral regions,
where the cartilage is covered by the meniscus [41]. These
results are surprising because other MRI techniques that
P
TrF cLF
pLF
LT
LF
LFTC
(a)
TrF
cMF
pMF
MT
MF
MFTC
(b)
Figure 2: Sagittal 3D DESS MR images showing anatomical
regions of interest commonly analyzed: (a) lateral femorotibial
compartment, (b) medial femorotibial compartment; P: patella,
TrF: femoral trochlear, MT: medial tibia, MF: medial femoral
condyle, cMF: weight-bearing part of the medial femoral condyle,
pMF: posterior part of the medial femoral condyle, MFTC: cMF
+ MT; LT: lateral tibia, LF: lateral femoral condyle, cLF: weight-
bearing part of the lateral femoral condyle, pMF: posterior part of
thelateralfemoralcondyle,LFTC:cLF+LT;themagentallineshows
the projection of the trochlear notch, the blue line the posterior
end of the medial and lateral femoral condyle, and the turquoise
line the 60% criterion (of the distance between the trochlear notch
and the posterior ends of the condyles) used to separate cMF
from pMF, and cLF from pLF, respectively. Images are from the
Osteoarthritis Initiative (OAI), a public-private partnership funded
bytheNationalInstitutesofHealthandconductedbytheOAIStudy
Investigators. For anatomical (region of interest) labels, also see
Figure 1 and Table 1.
have been validated for targeting speciﬁc macromolecules
of the cartilage, such as collagen, proteoglycans, or water
(T2 mapping, T1rho, dGEMRIC and others) [3, 42]h a v e
often been unsuccessful in discriminating between healthy
knees and knees with early OA, and they have generally not
been able to discriminate between diﬀerent radiographic OA
stages, in particular between early (preradiographic) OA and
radiographic OA [6, 8, 43].
3. Relative Performance and Relationship
betweenCartilageMorphology Measures
Most investigations dealing quantitatively with cartilage
morphology in OA have focused on the cartilage volumeArthritis 5
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Figure 3: Display of the rates of change (%/annum) and standardized response mean (SRM) in femorotibial cartilage compartments, plates
and subregions. (a) View of the weight-bearing part of the medial (cMF) and lateral femoral condyle (cLF) from inferior. (b) View of the
weight-bearing part of the cMF and cLF and of the medial (MT) and lateral tibia (LT) from posterior. (c) View of the MT and LT from
superior. For an explanation of the subregion abbreviations, please see Table 1. The data represent mean values from 3 studies: (i) the KLG3
participants of the A 9001140 study (n = 28) [29], (ii) the high risk (BMI > 30; KLG ≥ 2) subcohort from a ﬁrst release of OAI participants
(n = 54) [30], (iii) knees with neutral alignment from the MAK study (n = 74) [31].
(VC), but this outcome measure has a number of pitfalls.
The ability to discriminate between OA and healthy subjects
is limited, because cartilage volume is largely determined by
bone size, which increases the intersubject variability and
thus limits the ability to discriminate between subjects with
and without cartilage loss [44]. This has led to misinterpre-
tations in the literature, where it has been suggested that
a high VC may be protective of OA, because men show
higher VCs than women, and women are more susceptible
to knee OA than men. However, men have mainly larger
joint surfaces than women (and hence also larger VC) [45]
even after adjustment for body height and weight [46]; VC
should therefore not be directly compared between sexes.
In longitudinal studies, the subchondral bone area has been
shown to increase with aging, both in healthy reference
subjects and in OA patients [47–49]. Such eﬀects may mask
a reduction in cartilage thickness in OA when measuring
VC, because of the simultaneous expansion of the bone and
cartilage layer. Therefore, alternative outcomes have been
used, such as the VC normalized to the subchondral bone
area (VCtAB), or the cartilage thickness over the entire
subchondral bone area (ThCtAB) [44, 50].
In a recent study, Hudelmaier et al. [34] examined the
relationshipoftheaboveparametersandtheirtest-retestpre-
cision (at 3T) in a set of 33 subjects, both without and with
signs of radiographic osteoarthritis (reproducibility study).
Further, they compared these parameters at baseline and at
2-year followup in 28 subjects with advanced radiographic
osteoarthritis(sensitivitystudy).TheyfoundthattheACwas
larger than the tAB in all cartilage plates. In MT and LT,6 Arthritis
the cartilage volume divided by the total bone area (VCtAB)
was similar to the mean cartilage thickness over the total
bone area (ThCtAB.aMe), whereas in cMF and cLF the
VCtAB was somewhat greater than the ThCtAB.aMe. Dif-
ferent implementations of measuring the cartilage thickness
(e.g., minimal distance from bone to cartilage, or minimal
distance from cartilage to bone, or the average of both)
produced very similar values in all cartilage plates. The
maximal thickness over the total bone area (ThCtAB.Max)
was found to be almost twice as high as the mean thickness
(ThCtAB.Me) in the femorotibial plates. Reproducibility
errors for cartilage volume divided by the tAB (VCtAB) were
similar to those for the cartilage thickness over the total
bone area (ThCtAB) and tended to be smaller than those
for cartilage volume (VC). The reproducibility errors were
also similar for diﬀerent implementations of the thickness
measurements (see above). The maximal thickness over
the total bone area (ThCtAB.Max) and the average of the
top 1% greatest thickness values (ThCtAB.Mav) displayed
largerreproducibilityerrorsthantheaveragedmeancartilage
thickness over the total bone area (ThCtAB.Me) in all
cartilage plates, but reproducibility errors for ThCtAB.Mav
tended to be smaller than those for ThCtAB.Max. In terms of
the rate of (and sensitivity to) change, the cartilage volume
divided by the total bone area (VCtAB), and the mean
cartilage thickness over the total bone area (ThCtAB.aMe)
exhibited higher rates of change and greater SRMs (greater
sensitivity to change) than cartilage volume (VC) in MT, but
the diﬀerence was only marginal in cMF. The rates of change
and SRMs for cartilage thickness over the covered bone area
(ThCcAB) tended to be less than for cartilage thickness over
the total bone area (ThCtAB) and for cartilage volume (VC),
independent of the speciﬁc implementation, but tended to
be greater than those for cartilage surface area (AC) and
the cartilage covered bone area (cAB). ThCtAB.Max and
ThCtAB.Mav showed low rates of change and SRMs, in
particular in cMF. Table 2 lists the percent change, the SRM,
the signiﬁcance level, and the precision error (test-retest)
in MT and cMF (60% ROI) for diﬀerent morphological
variables from this study [34]. In summary, the normalized
cartilage volume (VCtAB) and the mean cartilage thickness
over the entire subchondral bone area (ThCtAB.Me) tended
to be more reproducible and more sensitive to change (SRM
up to −0.62) than cartilage volume (SRM up to −0.44),
cartilage thickness over the cartilaginous area (ThCcAB;
SRM up to −0.48) or maximal cartilage thickness (SRM up
to −0.35) [34].
Other publications also reported that the sensitivity
to change for ThCtAB or VCtAB was greater than for
VC [30, 31], whereas others found comparable SRMs for
these variables [51, 52]. A recent paper [31] reported that,
when cartilage loss was rapid (due to high mechanical
challenge in mal-aligned knees), “horizontal” cartilage loss
(i.e., an increase in denuded area = dAB) made a stronger
contribution to the total cartilage loss (= reduction in
ThCtAB), whereas when cartilage loss was relatively slow
in neutrally aligned knees, the “vertical” cartilage loss
(reduction ThCcAB) made a stronger contribution. This
ﬁnding will need to be conﬁrmed in other cohorts and
pathos-phyiological conditions. Wirth et al. [53] recently
explored the rate and sensitivity to change of the minimal
cartilage thickness (ThCtAB.Min) and applied the measure-
ment to central subregions of MT, LT, cMF, and cLF, respec-
tively. In 156 participants of the Osteoarthritis Initiative
(OAI), they found the one-year rate of the ThCtAB.Min
changes to be greater than those of ThCtAB.Me, but also
reported a greater standard deviation, so that ThCtAB.Min
was found to be less sensitive to change than ThCtAB.Me.
A recent paper [54] investigated the mathematical rela-
tionship between the above morphologic measurements
and explored whether a subset of the above variables fully
reﬂects diﬀerences observed in cartilage in cross-sectional
and longitudinal studies. The beneﬁts of this reduction
in variables are an increased statistical power due to less
multiple comparison issues, an improved understanding of
relationships between the morphologic measures of knee
cartilage, and a greater eﬃciency in reporting the results
in the literature. Buck et al. [54] used cross-sectional [55]
and longitudinal (baseline to 2 year followup) 3T MR image
data [29] from 152 women (77 healthy and 75 with knee
OA). They found that the total area of the subchondral bone
(tAB), cartilage thickness (ThCtAB.tAB), and the percentage
of denuded area of the subchondral bone (%dAB) explained
more than 90% of the cross-sectional and longitudinal
variation in the full set of cartilage morphology measures,
both in healthy and in osteoarthritic knees. The authors
therefore recommended these three variables as an eﬃcient
subset for describing structural status and change in knee
cartilage [54].
4. Reference Values for MRI-Based Knee
Cartilage Morphometry
Several groups have reported reference values of cartilage
morphology in healthy volunteers [44, 56, 57], including
templates/atlasesforcomparisonofcartilagethicknessdistri-
bution patterns between healthy reference subjects and OA
patients [50, 58] and reference values for the radiographic
joint space width (JSW) [59]. Beattie et al. [59]f o u n d
that measures of JSW did not signiﬁcantly decrease with
increasing decade, but remained fairly constant throughout
the lifespan in either sex; the same was observed for cartilage
morphometry measures. The authors suggested that there
may therefore be no need to diﬀerentiate a T- or Z-score
in OA diagnosis because cartilage thickness and JSW remain
constant throughout life in the absence of OA.
Recently, several authors have proposed the measure-
ment of certain anatomically deﬁned subregions within
cartilage plates to determine the spatial pattern of cartilage
loss [15, 60, 61]( Table 1). A recent analysis of a large
population-basedcohortreportedsex-speciﬁcnormalvalues
and potential maximal Z-scores for speciﬁc subregions of
the femorotibial cartilage [62]. The authors studied 686
Framingham participants (309 men, 377 women, age 62 ±
8 years) without radiographic femorotibial OA (“normals”)
and a subset of 376 Framingham participants (156 men,
220 women) who additionally had no MRI features ofArthritis 7
Table 2: Rate of change and sensitivity to change over 2 years in 28 participants with Kellgren-Lawrence grade [KLG] 3, and test-retest
reproducibility in 33 participants with KLG0 to KLG3 for various cartilage morphology metrics and regions of interest in the medial
femorotibial compartment.
MT cMF 60%
MC% SRM P RMSCV% MC% SRM P RMSCV%
VC −2.3 −0.44 .03 2.5% −3.5 −0.32 .10 2.6%
tAB 0.5 0.37 .06 1.0% −0.1 −0.04 .84 1.1%
AC −0.9 −0.33 .09 1.0% −1.7 −0.22 .26 1.3%
cAB −1.0 −0.29 .14 1.0% −3.0 −0.36 .07 1.1%
VCtAB −2.7 −0.59 .00 1.9% −4.0 −0.33 .09 2.0%
ThCtAB.aMe −2.6 −0.58 .01 1.9% −3.6 −0.31 .12 1.7%
ThCtAB.bMe −2.8 −0.62 .00 1.9% −3.3 −0.29 .13 1.9%
ThCtAB.cMe −2.5 −0.56 .01 2.0% −3.9 −0.33 .10 1.7%
ThCcAB.aMe −1.4 −0.43 .03 1.9% −1.5 −0.18 .34 1.7%
ThCcAB.bMe −1.5 −0.48 .02 1.9% −1.2 −0.15 .43 1.9%
ThCcAB.cMe −1.3 −0.42 .04 2.0% −2.0 −0.23 .23 1.7%
ThCtAB.aMax −1.4 −0.27 .17 4.4% 0.0 0.00 .99 2.8%
ThCtAB.bMax −1.7 −0.30 .12 4.2% 0.7 0.10 .61 3.3%
ThCtAB.cMax −1.1 −0.18 .35 5.3% −0.5 −0.09 .65 3.2%
ThCtAB.aMav −1.4 −0.31 .11 3.8% −0.3 −0.05 .79 2.5%
ThCtAB.bMav −1.7 −0.35 .07 3.5% 0.0 0.00 .98 2.8%
ThCtAB.cMav −1.3 −0.25 .19 4.5% −0.5 −0.09 .65 2.8%
MC%: mean change in %, SRM: standardized response mean (= mean change/SD of change), P: level of signiﬁcance of change using a paired t-test without
adjustmentformultiplecomparisons;RMSCV%:rootmeansquarecoeﬃcientofvariationoftest-retestacquisitionsatbaseline,withrepositioninginbetween
scans. For other abbreviations, please see Table 1. Note that values are given for the “long” femoral region of interest, that is, a 60% distance between the
trochlear notch and the posterior end of both femoral condyles.
cartilage lesions (“supernormals”). The Framingham par-
ticipants had thinner cartilage in the medial (3.59mm)
than in the lateral femorotibial compartment (3.86mm).
Medially, the femur displayed thicker cartilage (1.86mm)
than the tibia (1.73mm), and laterally the tibia thicker
cartilage (2.09mm) than the femur (1.77mm). The thickest
cartilagewas observed in central, and the thinnest in external
femoro-tibial subregions. The mean values in Framingham
“supernormals” and in non-exposed Osteoarthritis Initiative
(http://www.oai.ucsf.edu/) reference participants (partici-
pantswithoutsymptomsorriskfactorsofkneeosteoarthritis
(OA)) were very similar to those in Framingham “normals”.
The authors concluded that adequate reference values could
be obtained from populations without radiographic OA
(independent of risk factors and their speciﬁc MRI lesion
status), and that a cartilage thickness loss of approximately
27% is required for attaining a Z-score of −2.
5. Imaging Protocols for Measurement of
Cartilage Morphology IncludingValidation
QuantitativeworkperformedoncartilagewithMRIbetween
1994 and 2006 has been summarized previously [8, 9, 63]
and will not be repeated in this paper. Brieﬂy, for quantifying
cartilage morphology, water-excitation (or fat-suppressed)
T1-weighted spoiled gradient recalled echo acquisition in
the steady state (SPGR) or fast low angle shot (FLASH) at
1.5T or 3T represent the current gold standard [9, 64, 65]
for quantitative cartilage imaging. Double-echo steady-state
imaging (DESS) with water excitation has recently gained
interest because of the faster acquisition time and lower
slice thickness that can be achieved (Figure 2)[ 33, 36, 66–
68]. SPGR/FLASH sequences are readily available on almost
all MRI scanners and do not require speciﬁc hard- or
software, whereas the DESS is currently only available from
one vendor [33]. Because the DESS acquires two separate
images with diﬀerent echo times simultaneously, this addi-
tionally provides potential opportunity to estimate T2 and
to obtain morphological and compositional information of
the cartilage from a single high-resolution data set [69]. This
approach is still undergoing validation.
ThepreviouslymentionedOsteoarthritisInitiative(OAI)
(http://www.oai.ucsf.edu/) is a large research endeavor joint-
ly sponsored by the National Institute of Health (NIH), the
National Institute of Arthritis and Musculoskeletal and Skin
Diseases (NIAMS), and the pharmaceutical industry. This
study in a cohort of 4800 participants is currently focusing
onidentifyingimaging(andother)biomarkersforpredicting
and monitoring the onset and progression of symptomatic
knee OA using-3T MRI over a 4-year period (currently
being extended to 8-year followup). The OAI relies on a
nearly isotropic sagittal DESS sequence with water excitation
in both knees for quantifying cartilage morphology and
on a coronal FLASH sequence with water excitation in
one knee of all participants [70]. Sagittal images have the
advantage that all cartilage plates of the knee (including
the femoropatellar and femoro-tibial compartment) are
visualized, but suﬀer from partial volume eﬀects in the8 Arthritis
internal and external femoro-tibial subregions (Figure 3).
Coronal images, in contrast, can delineate the femoro-tibial
joint and axial images visualize the patella with little partial
volume eﬀects, but there is currently no consensus, which
of the above is the preferred orientation. A direct face-to-
face comparison of 2 year changes measured in coronal and
sagittal (SPGR) images revealed similar rates and patterns of
cartilage loss in the femoro-tibial joint [71].
Thetechnicalaccuracy(validity)andtest-retestprecision
(reproducibility) of quantitative cartilage measurements at
1.5T have been summarized in previous reviews [8, 9].
Analyses based on 1.0T images acquired with a dedicated
extremity scanner were found to be consistent with 1.5T
imaging, albeit less precise (reproducible) [72]. The use of
peripheral MRI scanners at lower ﬁeld strengths potentially
permits more widespread distribution of this technology,
especiallywhenaccesstohigh-ﬁeldMRIislimited.Quantita-
tive cartilage measurement at 0.2T have also been proposed
[18, 27, 28, 38–40] but have not been validated versus
external standards or measurement at higher ﬁeld strength.
However, they were shown to display substantially larger
precision errors than measurements performed at higher
ﬁeld strength. 3T cartilage imaging has been cross-calibrated
with 1.5T and lower precision errors than for 1.5T imaging
were reported when acquiring thinner (coronal) slices of
1.0mm on a 3T system [73]. Morphometric analysis from
DESS images, as acquired at 3T in the OAI, was found to
be consistent with that from FLASH images and to display
similar test-retest precision errors as FLASH in the femoro-
tibial joint, both using unpaired [33] and paired reading
approaches [67, 68]. In terms of sensitivity to change, Wirth
et al. [36]p e r f o r m e daf a c e - t o - f a c ec o m p a r i s o nb e t w e e n
FLASH and DESS over one year longitudinally in 80 knees.
The study conﬁrmed a high agreement between cartilage
thickness measures as determined from FLASH and DESS
cross-sectionally [33] and a similar sensitivity to change
of coronal FLASH and sagittal DESS. Further, the study
revealed a moderate correlation of the longitudinal one-
year changes, indicating that it may be adequate to pool
analyses obtained with FLASH and DESS in larger statistical
analyses [36]. Also, the authors found that analysis of every
2nd slice (i.e., obtaining information every 1.4mm) of the
sagittal DESS displayed similar SRMs as compared with
segmentation of every 0.7mm slice, both when either using
odd or even slice numbers [36]. Due to the near-isotropic
resolution of the sagittal DESS, multiplanar reconstruction
(MPR) in the coronal and axial planes is feasible [33, 67, 68].
Theratesof(andsensitivityto)changeofcoronalMPRDESS
was similar to that of coronal FLASH and sagittal DESS but
did not provide an advantage over the direct analysis of the
sagittal DESS [36].
Generally, results from diﬀerent vendors for cartilage
morphometry were shown to be comparable at 1.5T [74]
and at 3T [75], although one study reported slight oﬀsets
between diﬀerent scanners and protocols from the same
vendor [76]. At 3T, precision errors of cartilage morphom-
etry were observed to be similar for diﬀerent vendors and
scanners in a multicenter trial, and measurements were
relatively stable over a 3-month observation period [48].
The stability of geometric measurements over longer periods
on phantoms was found to be satisfactory and comparable
between several scanners of the same manufacturer over a 3-
year period in the OAI [77].
Use of diﬀerent coils has been evaluated at 3T. Although
the test-retest precision was similar between a phased array
and quadrature coil, certain oﬀsets in cartilage morphology
outcomes were observed [67]; these prohibit changes of the
coil between baseline and followup measurements. Cartilage
morphometry on images acquired 2 hours after intravenous
Gd-DTPAinjection(forthepurposeofsimultaneousdGEM-
RIC imaging) was reported to be highly correlated (r =
0.85−0.95)withthatonimagesobtainedbeforetheinjection
of the contrast agent at baseline [78]. However, a 2-year
longitudinal analysis in OA participants reported that the
sensitivity to change of post-Gd-DTPA cartilage imaging was
substantially less than that from images acquired prior to
intravenous Gd-DTPA injection [79].
6.Ratesof Change andSensitivityto
ChangeObservedinKneeOA
Numerous reports on longitudinal changes of cartilage
morphology in subjects with diﬀerent grades of knee OA
have been published [8, 9, 29–31, 36, 52, 53, 61, 80–87].
These studies have revealed variable results with regard to
the rates of cartilage loss and SRM [6, 8, 9] Two studies
reportedalmostnolossincartilagevolumeovera1-year[87]
and 3-year period [80], respectively, whereas other studies
reported up to 7% annual cartilage loss in the femoro-
tibial joint [82]. Reasons for this may include variability
in imaging and image analysis technology, diﬀerences in
risk factor proﬁles between cohorts, diﬀerences in study
duration, experience and blinding of the readers, and others.
Ar e c e n ts t u d y[ 88] tested the hypothesis that “Proof of
Concept” studies with shorter durations may be achievable
with 3T MRI, by selecting populations at high risk of rapid
medial femoro-tibial progression and using advanced image
analysis techniques. Female participants with knee pain, a
body mass index ≥25, and radiographic evidence of medial
OA and varus mal-alignment were monitored over 3 and 6
months, respectively, and anatomically corresponding ROIs
were identiﬁed on each image by using a three-dimensional
statistical shape model of the bone surface. The primary
outcome was the change in cartilage thickness in the aspect
of cMF that is exposed within the meniscus window during
articulation, excluding the peripheral aspects of the femoral
surface. Despite these eﬀorts, no change in ThCtAB was
detected at P<. 05 at 3 or 6 months followup; the mean
change at 3 months from a log-scale ANOVA model was
−2.1% [95% conﬁdence interval (CI) (−4.4%, +0.2%)] and
the change over 6 months was 0.0% [95% CI (−2.7%,
+2.8%)]. Changes in the lateral tibia were signiﬁcant at 6
month followup (−1.5%), but only without correction for
multiple comparisons. The authors concluded that the small
inconsistent compartment changes and the relatively high
variability in cartilage thickness changes seen in the study
provided no conﬁdence for a 3- or 6-month study, not evenArthritis 9
based on a patient population selected for rapid progression
[88].
Analyses of the ﬁrst release of 160 participants of the OAI
progressioncohort(baselineandyear1followupdata)found
signiﬁcant change of up to 2% per annum, with substantially
higher rates of progression in the cMF than in the MT,
and higher rates in LT than in cLF [30, 52, 53]. However,
this pattern of change was not entirely consistent across
cohorts,whenfocusingontheSRMratherthanontherateof
change [10, 29, 31]. Several studies therefore have taken the
approachofreportingtheaggregatethicknessinthetibiaand
weight-bearing femur (MFTC or LFTC) [29–31, 36, 67, 89].
One study suggested that longitudinal changes in VC in the
tibia and in the weight-bearing femur are highly correlated
[82], and that the measurement of only tibial cartilage is
thereforesuﬃcient.However,giventhatatleastsomecohorts
appear to display larger changes and higher SRMs in the
weight-bearing femur than in the tibia [30, 52, 53], this
approach has limitations.
Medial and lateral femoro-tibial cartilage loss as well as
patellar cartilage loss were found to be not signiﬁcantly asso-
ciated with each other [90]. The ratio of medial versus lateral
cartilage loss was reported to be 1.4:1 in knees with neutral
biomechanical alignment, consistent with higher mechanical
loads being transferred across the medial compartment in
neutral knees [31]. In varus knees, the ratio was 3.7:1, and
in valgus knees it was 1:6.0, conﬁrming that knee alignment
is an important determinant of medial versus lateral rates of
cartilage loss [31].
After anterior cruciate ligament rupture, a reduction
of cartilage volume and thickness was observed in the
femoral trochlea (TrF), while an increase was found in
the weight-bearing medial femur (cMF) [91]. The latter
observation may be consistent with cartilage swelling or
hypertrophy observed as a sign of early OA in various
animal models [92–96]. A recent cross-sectional study found
signiﬁcantly thicker cartilage in the medial compartment of
women with medial radiographic KLG2 OA compared with
healthy knees [55] and signiﬁcantly thinner cartilage in some
subregions in knees with medial radiographic OA with joint
space narrowing (JSN, i.e., KLG3). These observations were
conﬁrmed by a large cross-sectional analysis of more than
1000 OA participants, in which the authors [97]c o n ﬁ r m e d
a signiﬁcantly greater cartilage thickness in KLG2 compared
to healthy knees, speciﬁcally in the external subregion of the
medial femur (ecMF), both in men and in women. These
ﬁndings have suggested that there may be an initial phase
of cartilage swelling/hypertrophy in knee OA, particularly
at the KLG2 stage, which is characterized by osteophytes
without a reduction in JSW. This has been supported by
recent longitudinal observations by Buck et al. [98]w h o
explored whether the 2-year longitudinal change in cartilage
thickness in femoro-tibial subregions (see below) of knees
with radiographic osteoarthritis (ROA) diﬀered from that
in healthy knees. Knees from 75 women with deﬁnite
signs of medial radiographic OA were compared with 77
asymptomatic healthy controls without radiographic OA.
A substantial portion of ROA knees were classiﬁed as having
longitudinal cartilage thinning (28%) or thickening (20%)
in at least one medial femoro-tibial subregion compared
with longitudinal changes in healthy knees, and only 5%
showed both subregional thinning and thickening at the
same time, across (diﬀerent) medial subregions. Whereas the
estimated proportion of KLG3 knees with signiﬁcant medial
cartilage thinning (46%) was substantially greater than that
with cartilage thickening (18%), the estimated percentages
of KLG2 knees with signiﬁcant medial thinning (20%) and
thickening (23%) were similar. The subregion in which
cartilage thickening was observed was ecMF in the majority
of the cases. The authors concluded that OA may not be
a one-way road of cartilage loss and that particularly in
early radiographic OA, cartilage changes may occur in both
directions simultaneously, that is, cartilage thinning and
cartilagethickening.Thismayprovideareasonwhyrelatively
small (and variable) rates of change have been observed in
OA cohorts, and why short-term trials are challenging [88].
7. SpatialPatternsof CartilageLoss in
Knee OA asDerivedby SubregionalAnalysis
As mentioned above, recent eﬀorts have been focused on
measuring anatomically deﬁned subregions within cartilages
[15, 60, 61], with the aim of elucidating spatial pattern of
cartilage thinning, and to potentially identify (sub) regions
with increased rates of (and sensitivity to) cartilage loss in
intervention trials.
7.1. Cross-Sectional Studies. The previously mentioned
cross-sectional study by Hellio Le Graverand et al. [55]
reported that cartilage “thinning” in female knees with
medial JSN (KLG3) was most evident in the central sub-
region of the cMF and in the external subregion of the
MT, and in the internal subregion of the LT. This was
extended by the study of Frobell et al. [97], who reported
that the external medial tibia showed the greatest reduction
in cartilage thickness (z-scores −5.1/−5.6 in men/women) in
knees with medial joint space narrowing (OARSI JSN) grade
3 and the external lateral tibia (z scores −6.0 for both sexes)
the greatest reduction in knees with lateral JSN grade 3. The
authors, however, reported that at least 25% of the average
normal cartilage thickness was maintained in all subregions
of end-stage ROA knees.
Although these diﬀerences were generally not aﬀected
when possible eﬀects of demographic covariates (height and
BMI) were considered [55, 97], it is diﬃcult to exclude
confounding by interperson diﬀerences in cross-sectional
studies. Therefore, Eckstein et al. [99] performed a within-
person, between-knee comparison in 80 participants of the
OAI who displayed medial JSN in one knee, but no medial
or lateral JSN in the contralateral knee. The strength of
this approach is that it rules out confounding from person-
speciﬁc demographic features, and that it is potentially more
sensitive to detecting diﬀerences cross-sectionally, given the
much smaller magnitude of side diﬀerences between knees
within the same (healthy) person compared with diﬀerences
across (healthy) subjects [100]. The authors estimated the
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(5.2%) in the medial femoro-tibial compartment (MFTC)
with JSN OARSI grade 1, 630μm (18%) with OARSI grade
2, and 1560μm (44%) with OARSI grade 3 [101, 102]. Side
diﬀerences were greater in cMF than in MT, and greater in
MT than in pMT [99]. Within MT the greatest diﬀerences
were observed in the external and central subregions, and
within MF the greatest diﬀerences were observed in the
centralsubregionoftheweight-bearingportionofMF.When
evaluating A-P subregions in the MF [103], the greatest
diﬀerencesbetweenmJSNandcontra-lateralno-mJSN knees
were observed in regions located between 30◦ and 75◦ at the
MF.
7.2. Longitudinal Studies. Pelletier et al. [61] reported that
the rate of change in cartilage morphology in the central
aspects of the femoro-tibial joint exceeded that in total
cartilage plates, but found that the SRM was not improved
because of the higher variability of subregional changes [51].
Wirth et al. [53] found the sensitivity to change (SRM) in the
central MT to be slightly greater than for the total MT in a
subsample of OA Initiative participants, but this ﬁnding was
not conﬁrmed in the cMF.
Figure 3 summarizes the rates of change (%/annum) and
thesensitivity tochange(SRM)fordiﬀerentsubregions from
three published studies.
(a) A 2-year multicenter study at 3T (Pﬁzer A 9001140).
Because healthy reference participants and partici-
pants with KLG 2 did not show signiﬁcant changes
in cartilage morphology [29], results from KLG 3
participants were used (n = 28).
(b) The 2nd cohort included is a ﬁrst release of baseline
and year 1 followup data from the OAI progression
subcohort [53]. Results of a subcohort with a high
risk of progression (BMI > 30; KLG ≥ 2) were
included (n = 54).
(c) The 3rd cohort included was from the MAK study
[11, 31]. Data from a subcohort of participants with
neutral knee alignment were included in the analysis
(n = 74).
The central and external part of cMF, and the external
and central aspect of MT displayed the relatively greatest
change across subregions in the MFTC (Figure 3). With
the exception of the external medial femur, these regions
consistently displayed greater changes than the total cartilage
plate across the studies. In the LFTC, the central, internal,
and posterior LT displayed the relatively greatest changes,
and no relevant average changes (across studies) were
observed in the cLF (Figure 3). Rates of change in the central
and internal LT were consistently greater than those for the
total cartilage plates. Please note that the patterns for the
sensitivity to change (SRM; Figure 3) are similar to those
of the rates of change, but not identical. Consistent with
other observations in the literature [51], we found that the
sensitivity to change in the subregions was not consistently
higher than in the total plates across the above three studies.
However, analysis of the central aspects (subregions) of
the medial and lateral femoro-tibial compartments revealed
consistently greater SRMs than the analysis of the entire
MFTC and LFTC, respectively.
Wirth et al. [103] recently presented a method which
extended the previously developed method of subregions
in the weight-bearing femoro-tibial joint [15] to anterior-
posteriorly spaced subregions across the entire femoral
condyle. This method was applied to participants from
the OAI and conﬁrmed that cartilage thinning in the
anterior (weight-bearing) region of the MF was greater
than that in the posterior aspect of the MF. The authors
reported the greatest longitudinal changes (and SRM) to
be located at 30 to 60◦ (from the trochlear notch [0◦]t o
the posterior/superior end of the MF (150◦), with a slight
variation between knees with diﬀerent OARSI JSN grades.
7.3. Ordered Value Approach (Subregion Ranking). Buck et
al. [104] analyzed patterns of subregional cartilage change
[15] in individual knees and found highly variable patterns
of change. To compare the rate of change between two
groups (i.e., ROA knees with healthy knees, or DMOAD
treated knees with control knees) he therefore recommended
the use of ordered values (OVs) or ranking system, in
which the subregional changes (in MFTC) were assigned
to ranked orders in each knee, that is, the subregion
with greatest magnitude of cartilage thinning to OV1, the
one with the second greatest magnitude to OV2, and the
one with the smallest magnitude of cartilage thinning (or
with the greatest magnitude of cartilage thickening) to the
highest rank order. When averaging longitudinal changes
in cartilage thickness (ThCtAB) across these OVs (which
vary in location across subjects), the authors found that the
minimal P value (Wilcoxon) for the diﬀerences in 2-year
change in medial cartilage thickness in a relatively small
number of knees with radiographic OA and JSN (KLG3)
versus healthy knees (KLG0) was P = .001, with OV1 to
OV4 displaying signiﬁcant diﬀerences between both groups.
When averaging changes across compartments, plates, or
subregions (i.e., the conventional approach), in contrast,
only one medial subregion displayed signiﬁcant diﬀerences
(in the rate of change) between KLG 3 and KLG0 knees
(P = .037). Cartilage thickening was signiﬁcantly greater in
knees with radiographic OA (deﬁnite osteophytes) without
JSN (KLG2) versus KLG0 knees in one medial subregion
using the conventional approach (P = .02), but in two OVs
using the ordered values approach (minimal P = .007).
The authors concluded that the ordered values approach was
more sensitive in detecting cartilage thinning in KLG3 versus
KLG0, and cartilage thickening in KLG2 versus KLG0 knees,
respectively. The authors also suggested that this method
was particularly useful in the context of comparing a cohort
treated with a disease-modifying OA drug versus one treated
withaplacebo,orindetectingriskfactorsofOAprogression.
Wirth et al. [105] recently extended this approach to
include eight medial and eight lateral (n = 16) subregions.
They reported signiﬁcantly greater cartilage loss in KLG3
than in KLG2 knees, the ordered value approach again dis-
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approach. This opens new possibilities of including partici-
pants with medial and lateral OA (or with varus and valgus
mal-alignment) into a study, without the need of deﬁning
cartilage thickness changes in a certain compartment, plate
or subregion as the primary endpoint. The relevant question
wouldthenNOTbewhetheracertainriskfactorisassociated
with or whether a drug can modify cartilage thickness
changes in a given location (region), BUT whether the risk
factor is associated with or whether the drug can modify
the change in cartilage thickness wherever it occurs in an
individual knee.
8. Comparison of MRI Changes with
RadiographicChanges inKnee OA
Several studies found only weak correlations between MRI-
detected cartilage loss and OA progression in radiography
[83, 87, 106]. However, a recent publication reported a
stronger correlation when the longitudinal reduction in JSW
in radiographs was compared with cartilage loss in the
central aspect of the MFTC [61] .W h e r e a ss o m es t u d i e s
found a higher rate and sensitivity to change of MRI-
basedmeasurementsofcartilagemorphologycomparedwith
radiography [83, 85, 107] ,ar e c e n ta n a l y s i sr e p o r t e da
somewhat greater SRM (−0.62) for ﬂuoroscopy-based Lyon
SchussradiographyversusThCtABoftheMTmeasuredwith
MRI (−0.59) [29]. However, the authors found the SRM for
ﬁxedﬂexion radiography, acommonlyusednonﬂuoroscopic
protocol that also is used in the OAI [108–112], to be
substantially less (SRM = −0.20) in the same study [29].
The authors argued that the relatively high SRM of the
minimal JSW measured by Lyon Schuss may be due to
the ﬂuoroscopic guidance providing optimal alignment of
the anterior and posterior tibial rim, and to radiography
being performed under weight-bearing conditions where
the cartilage tissue is compressed, while MRI is performed
in a supine non weight-bearing position. Also, it must
be kept in mind that radiographic assessment of JSW
depends also on meniscus extrusion, and not only on
cartilage thickness [113–115] and that meniscus pathology,
in particularly subluxation, can therefore cause changes in
JSW over time in the absence of cartilage loss. Duryea et
al. recently compared the responsiveness (=sensitivity to
change) of radiography with that of MRI in the ﬁrst release
of the OAI cohort (150 subjects) over 12 months [116].
The radiographic JSW measurements relied on automated
software to delineate the femoral and tibial margins [117,
118]. Measures included the medial compartment minimum
JSW and JSW at ﬁxed locations that were compared to
previously published cartilage morphology measures [52].
The SRM value for radiographic JSW measured at the
optimal ﬁxed location was −0.32 compared to −0.39 for the
most responsive MRI measure. For a subsample of KLG2 or
KLG3 knees, the most responsive SRM values were −0.34
and −0.42, respectively. The authors concluded that new
(ﬁxed distance) measures of JSW changes were superior to
conventional minimal JSN measures and provide a similar
sensitivity to change as MRI.
9. Risk Factorsof Cartilage Loss in
KneeOAasIdentiﬁed byQuantitative
CartilageImagingwith MRI
Great interest is directed at identifying risk factors (predic-
tors) of subsequent cartilage loss, both to understand the
pathophysiology of the disease and to be able to identify
so-called fast progressors for inclusion in pharmacological
intervention studies that attempt to show protection from
structural change over relatively short periods (e.g., [88]).
This paragraph will focus on studies that have reported
correlations between risk factors of progression and quan-
titative measures of cartilage morphology, but not those
that have relied on semi-quantitative scoring of MRI or
quantitative measurement of JSW. The list of (potential) risk
factors for cartilage loss is not complete, but encompasses
importantexamplesexaminedbothfromcross-sectionaland
longitudinal studies. Risk factors associated with higher rates
of progression were the following.
Advanced Radiographic OA and Low Cartilage Thickness at
Baseline. Opposite to earlier assumptions and a synthesis of
evidence from radiographic studies [119], recent evidence
suggests that advanced radiographic OA (JSN) is a strong
(if not the strongest) predictor of fast progression (i.e.,
cartilage loss). There has been evidence that knees with
higher KL grades and increased JSN [29, 30, 53, 61] display
greater rates of (and sensitivity to) change than those with
lower KL grades and without baseline JSN. An analysis
of speciﬁc radiographic features in a sample from the
OAI found that osteophyte status (at baseline) was not
associated with medial cartilage loss over 12 months but that
knees with medial joint space narrowing showed a trend
towards higher rates of change than those without, and
that knees with medial femoral subchondral bone sclerosis
displayed signiﬁcantly greater rates of progression than those
without [120]. The same study also found that low baseline
cartilage thickness was a strong predictor of longitudinal
loss in cartilage thickness [120], whereas an earlier study
had reported that higher baseline cartilage volume [81]w a s
strongly associated with increased cartilage loss. A within-
person, between-knee comparison in painful knees selected
from the OAI [35] recently reported that the cartilage loss
was greater in knee with radiographic JSN than in contra-
lateral knees without JSN in the same subjects, and that
the side diﬀerences were greater with higher grades of JSN.
Progression was particularly fast in the small subgroup with
OARSI JSN grade 3 knees [35].
MeniscusExtrusionandTears/Damage[61,84,85]. Meniscus
tears were found to be associated with greater tibial plateau
bone area, but not with reduced tibial cartilage volume in
a two year longitudinal study [121]. However, Sharma et
al. [11] reported a signiﬁcant relationship of cartilage loss
with meniscus tears, albeit not with meniscus extrusion. A
recentanalysisfoundsite-speciﬁcrelationshipsbetweenlocal
meniscus tears and subregional cartilage loss, suggesting that
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the meniscus was associated with increased cartilage loss in
adjacent tibial subregions [122]. Crema et al. [123]r e p o r t e d
grade 2 and 3 medial meniscus lesions to be associated
with greater cartilage loss in the femoro-tibial compartment,
but not grade 1 lesions (=intrasubstance meniscus signal
changes). They concluded that the protective function of
the meniscus was preserved in case of these early lesions.
Recent evidence suggests that the meniscus may undergo
a phase of hypertrophy in OA [124, 125]. Raynauld et al.
[126] observed that selecting a subcohort of participants
with meniscus tears/extrusion did not improve the ability to
identifytreatmenteﬀectsofapotentiallystructuremodifying
drug, because of the larger standard deviation of the change
in the participants with meniscus pathology.
Knee Malalignment and Adduction Moment. As t r o n gr e l a -
tionship was observed between (varus and valgus) mal-
alignment and the ratio of cartilage loss in MFTC versus
LFTC [11, 31, 127, 128]. After adjustment for meniscus
changes, the study by Sharma et al. [11] found that varus
malalignment and medial meniscus damage both predicted
medial tibial cartilage volume (and thickness) loss. In
contrast, medial-lateral joint laxity, measured with a device
applying a ﬁxed varus and valgus load, was not found to
have consistent eﬀects and was not a signiﬁcant predictor
o fc a r t i l a g el o s si nm o d e l sf u l l ya d j u s t e df o ra l i g n m e n t
and meniscus damage [11]. Teichtahl et al. [129] showed
an increase in varus mal-alignment between baseline and
followup to be associated with an increase in the rate
of MT cartilage loss, whereas there was no signiﬁcant
correlation with the rate of cartilage loss of the LT. The
authors concluded that methods to reduce progression of
varus alignment may also delay the progression of medial
femoro-tibial OA. Frontal plane knee valgus mal-alignment
was also correlated with patellar cartilage loss [130]. In
a largely nonarthritic cohort, in contrast, no correlation
between cartilage loss and mal-alignment was identiﬁed
[131]. A recent cross-sectional analysis revealed that a higher
peak knee adduction moment was observed in participants
with medial compared to those with lateral meniscus tears
[132]. Participants with a higher knee adduction moment
displayed a larger medial meniscus extrusion and lower
medialmeniscusheight, whereastheinverserelationship was
observed for the lateral meniscus. A higher knee adduction
moment was also associated with a higher ratio of the medial
to lateral tibial subchondral bone area, whereas cartilage
thickness and denuded areas in the tibia and femur were not
related to the knee adduction moment. Similar results were
found for the relationship between knee adduction angular
impulse and meniscus, cartilage, and bone morphology
[132].
High BMI. In contrast with a synthesis from the radio-
graphic literature [119], MRI-based studies on progression
have found higher rates of cartilage loss in subjects with a
high BMI [30, 53, 61, 83, 85, 90, 133]. This relationship was
also suggested to exist in the patella in subjects without OA
[134].
Bone Marrow Alterations [61, 85]. Raynauld et al. [126]
reported that although bone marrow lesions and cysts did
not increase signiﬁcantly in size over 24 months in an
OA cohort, there was a signiﬁcant correlation between size
change of bone marrow lesions and cysts with the loss of
cartilage volume in the medial femoro-tibial compartment.
A relationship between very large bone marrow lesions and
lateral tibial cartilage loss was also reported in asymptomatic
persons [135, 136].
Focal Cartilage Lesions or Defects as Graded by Visual Scoring
and Denuded Areas as Determined Quantitatively from MRI.
Cartilage defects at baseline (visual scoring) appeared to be
associated with longitudinal measurement of quantitative
cartilage loss in the same compartment in OA subjects [137,
138],althoughthesecondofthetwoabovestudies[138]only
found a signiﬁcant relationship in the femoro-patellar but
notinthefemoro-tibialjoint.Otherstudiesreportedthatthe
presence of cartilage defects predicted knee cartilage loss also
in asymptomatic individuals without radiographic knee OA
[139, 140]. It was hypothesized that tibial subchondral bone
areaexpansionmayleadtothedevelopmentofkneecartilage
defects(whichareassociatedwithfuturecartilageloss)andis
predictive of the need for knee joint replacement in subjects
with knee OA, independent of radiographic change [141].
Morphometric studies have recently provided evidence that
areas of denuded subchondral bone (dABs), as determined
by segmentation at baseline [142], also predict subsequent
cartilage loss [120, 143]. Hunter et al. [143] reported that
in a subsample of knees with no denuded area (at baseline)
the SRM for subsequent cartilage volume loss was −0.25,
whereasitwas −0.30inthekneeswithintermediatedenuded
areas and −1.0 in knees in knees with severe denuded
areas. Denuded areas were observed to either originate
from cartilage loss or from internal osteophytes [142]. In a
subsample from the OAI, almost half of the men and a third
of the women displayed dABs; 61% of the dABs represented
internal osteophytes. One of 47 knees with KLG0 displayed
any dAB, whereas 29 of the 32 KLG4 knees were aﬀected.
There were signiﬁcant relationships of dAB with increasing
KL grades (P<. 001) and with ipsi-compartimental JSN.
Internal osteophytes were more frequent laterally (mainly
posterior tibia and internal femur), whereas full thickness
cartilage loss was more frequent medially (mainly external
tibia and femur).
Molecular Markers from Biological Fluids. Dam et al. [144]
reported a signiﬁcant association between baseline levels of
the C-terminal telopeptide of type II collagen (CTXII) and
cartilage loss in 158 study participants (36 with ROA at base-
line) using low ﬁeld (0.2T) MRI–based cartilage loss. In this
study, elevated CTXII was also associated with radiographic
progression (by KLG or JSN, but did not reach statistical
signiﬁcance [144]. Bruyere et al. [145] followed 62 patients
with knee OA using 1.5Tesla MRI and found that baseline
cartilage oligomeric matrix protein (COMP), C-terminal
telopeptide of type I collagen (CTXI), and CTXII did
not correlate with one-year changes in cartilage thickness,Arthritis 13
but longitudinal increase in CTXII over three months did
(P = .0 4 ) .P e l l e t i e re ta l .[ 146] reported higher baseline
values of interleukin 6, C-reactive protein, and COMP to
be predictive of greater cartilage loss with MRI, whereas
Ecksteinetal.reportedarelativelylargeset(n = 16)ofdiﬀer-
ent molecular markers of bone formation, bone resorption,
cartilage synthesis, cartilage degradation, and inﬂammation
take at baseline to be substantially less predictive of cartilage
loss than simple radiographic measures, such as reduced
JSW, or low baseline cartilage thickness [147].
Other Risk Factors. Some evidence has been provided that
smoking may be associated with increased cartilage loss
[140, 148, 149] in line with previous radiographic studies,
but other factors such as age, sex, pain, function, physical
activity levels, synovitis (eﬀusion), sex hormone levels, and
serum or urine biomarkers were not consistently found to
beassociatedwithcartilagethinningmeasuredquantitatively
with MRI and studies (including those with radiography)
have produced partially contradictory results [119].
10. The Correlationof MRI-Based Cartilage
Loss with Clinical Outcomes and Treatment
Response inKnee OA
Estimatesoftibialcartilagelossovertwoyearsweresuggested
to be correlated with those over 4.5 years, albeit the authors
did not report the consistency of the longitudinal changes
in the second versus the ﬁrst observation period [86]. More
importantly, however, the rate of change in VC over 2
yearswassigniﬁcantlyassociatedwithtotalkneearthroplasty
(TKA) at year 4 [150]. For every 1% increase in the rate of
cartilage loss there was a 20% increased risk of undergoing
TKA and participants in the highest tertile of tibial cartilage
loss had a 7.1 higher odds of TKA than those in the lowest
tertile. In contrast, radiographic scores of OA did not predict
TKA in the same study. A more recent study concluded
from the same sample that when subchondral bone cysts
were present, cartilage loss and risk of knee replacement
were higher than if only bone marrow lesions were present,
suggesting that cysts identify those that may beneﬁt most
from the prevention of structural disease progression [151].
These are important ﬁndings as they link longitudinal
changes in cartilage morphology as a potential surrogate
measure of disease progression, to a clinical outcome (i.e.,
how a patient feels or functions, or how long the knee
“survives” [TKA]).
Raynauld et al. [107] recently reported that licofelone
(a drug that inhibits both cyclooxygenase and lipoxygenase)
signiﬁcantly reduced cartilage loss over time when aver-
aged over both femoro-tibial compartment, and that MRI
was superior to radiographs in demonstrating a structure
modifying eﬀect in this multicentre trial. Interestingly, the
eﬀects were signiﬁcant only in the lateral, but not in the
medial compartment, although the participants had been
selected for medial femoro-tibial radiographic OA, and the
medial compartment had thus been deﬁned as the primary
endpoint. To date, no structure or disease-modifying drug
(SMOAD or DMOAD) has yet been approved by regulatory
agencies, neither based on radiographic nor on MRI-based
evidence of structure modiﬁcation in knee cartilage.
11. FutureDirectionsof the Field
In the Osteoarthritis Initiative, baseline, 12-, 24-, and 36-
month followup clinical, radiographic, and MRI data have
been made publicly available for approximately 4800 partic-
ipants of the OAI cohort (http://www.niams.nih.gov/ne/oi/),
and central readings of ﬁxed ﬂexion radiographs (OARSI
a t l a ss c o r e s[ 101, 102]), quantitative measurements of radio-
graphic joint space width (JSW) as well as quantitative car-
tilage morphology outcomes from MRI are available for var-
ious subsets that have been read/analyzed by expert reading
facilities. These and the results of other large epidemiological
studies will provide ample opportunity for collaborative
research and should allow the research community to make
rapid progress in understanding the risk factors involved
in quantitative cartilage loss in OA. Most importantly, it
will allow one to determine which imaging biomarkers can
best predict clinical outcomes, such as real or virtual TKA
[152]. This will be an important step in validating novel
cartilage imaging biomarkers and approaches as surrogate
measures of disease progression, particularly in therapeutic
intervention trials. Once the clinical importance of these
imaging biomarkers are established, further improvements
in imaging hardware, coils, sequences, and image analysis
algorithms may foster a more automated analysis of cartilage
morphology, composition, and other articular tissues than
currentlypossible.Thiswillbeofparticularimportanceonce
structure- or disease-modifying drugs become available, as
this may require monitoring the treatment response in large
sets of OA patients. Currently, quantitative MRI of articular
cartilage represents a powerful research tool in experimental,
epidemiological, and pharmacological intervention studies.
Once structure- or disease-modifying drugs (SMOADs or
DMOADs) will become available, quantitative MRI of the
cartilage may also play a more important role in clinical
decision making and practice.
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